Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-10-30 00:00:00 ET · period of report 2025-10-30 · accession 0001231589-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-10-30 | 2025-10-30 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $450.34 | -11.0K | 47.1K | -19% | -$4.95M |
| DT | 2025-10-30 | 2025-10-30 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DT | 2025-10-30 | 2025-10-30 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -11.0K | 22.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-30 | S | D | 393 | $454.15 | 36,781 | D | — | — | (F8) This transaction was executed in multiple trades at prices ranging from $453.90 to $454.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-10-30 | S | D | 1,285 | $452.33 | 37,174 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $452.10 to $452.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-10-30 | M | A | 11,000 | $135.42 | 47,781 | D | — | — | |
| 4 | Common | Common Stock | 2025-10-30 | S | D | 1,143 | $448.56 | 45,996 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $447.94 to $448.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2025-10-30 | S | D | 3,441 | $449.46 | 42,555 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $448.95 to $449.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2025-10-30 | S | D | 2,247 | $450.64 | 40,308 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $450.03 to $451.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2025-10-30 | S | D | 1,849 | $451.57 | 38,459 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $451.04 to $452.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2025-10-30 | S | D | 642 | $447.34 | 47,139 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $446.855 to $447.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Derivative | Stock Option | 2025-10-30 | M | D | 11,000 | $0.00 | 22,000 | D | $135.42 · 2023-03-15 to 2027-03-15 | 11,000 Common Stock |